- On-Line
Presentations
e-mail inquiries accepted
by faculty during the summit
|
 |
Health Plan Issues and Opportunities Under the MMA: More Than Meets the Eye
Stephen Wood, Principal
Reden & Anders |
|
- The Medicare Modernization Act of 2003 presents both opportunities and risks for health plans and health insurance companies. This session will explore the implications of the Act on payment rates, member premiums, plan design, likely competitive responses and the future role of employers. New product options such as Health Savings Accounts, Prescription Drug Plans and Regional PPOs will be discussed.
|
|
The New Medicare Drug Benefit: What Investors and Analysts Need to Know
(Or "Washington Eye for Wall Street Guy").
R. Alexander Vachon, III, Ph.D., President
Hamilton PPB
|
|
- This 34 slide presentation addresses the
significant aspects of the
Medicare Prescription Drug, Improvement and Modernization Act from both a
political and financial perspective.
|
|
The Implications of the New Medicare Prescription Drug Legislation to Pharmaceutical Manufacturers
G. Lawrence Atkins, Senior Director, Public Policy & Reimbursement
Schering-Plough Corporation |
|
- This presentation highlights issues and opportunities raised under the
Medicare Prescription Drug, Improvement and Modernization Act from the
pharma perspective,
including: Medicare-Approved Drug Discount Cards; Medicare Prescription Drug Benefit; Transfer of “Dual-Eligibles” to Medicare Drug Benefit; Federal Low-Income Subsidies; Medicare Advantage (MA) and Prescription Drug Plans (PDPs); Electronic Prescribing Standards; Payment Changes for Existing Medicare-Covered Drugs; Hatch-Waxman Reforms; and Canada Importation
|
 |
- Exploring the Interaction between Medicare Part B and Medicare Part D
- Jennifer R. Breuer, Partner
Gardner, Carton & Douglas
|
|
- This 34 slide presentation addresses specific
issues regarding prescription drug reimbursement and coverage under Part B
benefits, in the context interacting with the new Part D benefits.,
Supplemental tables are also provided detailing Part B drug reimbursement
for 2004 and 2005.
|
|
- How will PBMs Participate in the New Medicare Prescription Drug
Program?
- Terry S. Latanich, Government Affairs Consultant
Medco Health Solutions
|
|
- Mr. Latanich addresses the role for
participating PBMs in the Medicare prescription drug discount card program,
as well as in the Part D drug benefits effective in 2006.
|
|
- Implications of the Medicare Prescription Drug Legislation to MediGap Insurers
Larry A. Oday, Partner
Vinson & Elkins LLP
|
|
- This presentation provides two briefs
addressing provisions of the
Medicare Prescription Drug, Improvement and Modernization Act that directly
affect Medicare Supplement (MediGap) plans and policies.
|
|
- Medicare Prescription
Drug Discount Cards
Clive Riddle, President
MCOL
|
|
- Get detailed information on the Medicare
Prescription Drug Discount Card program that becomes effective in June. An
Overview is provided, followed by a discussion of the Transitional
Assistance Program, provisions regarding prescription drugs, enrollment
provisions, communication and marketing of the program by Medicare, and a
listing of the approved card sponsors and health plan sponsors.
This
presentation is also available as a video clip
|
|
- Chronic Care Improvement Under the Medicare Modernization Act
- Vince Kuraitis, JD, MBA, Principal
- Better Health Technologies
|
|
- Understand Medicare's problem with chronic disease patients
- Understand Medicare's demonstration projects focusing on patients with chronic conditions
- Understand implications and opportunities for providers, disease management companies, health plans, and others
This
presentation is also available as a live
audioconference.
|
|
- Medicare Meets Disease Management: Exceeding Expectations
- Jeffrey Odell, Vice President
- Health Management Corporation
|
|
- The introduction of disease management programs for the Medicare population will deliver better health outcomes, cost savings and a myriad of other benefits for all stakeholders--with a profound impact on the entire DM industry.
This presentation is also available as a live
audioconference.
|
|
- Will the Medicare Competition Demonstrations Scheduled for 2010 Ever Take Place?
- Joseph R. Antos, Wilson H. Taylor Scholar in Health Care and Retirement Policy
- American Enterprise Institute
|
|
- This presentation briefly summarizes the
Medicare Competition Demonstration provisions included in the
Medicare Prescription Drug, Improvement and Modernization Act, along with
consideration of potential "death spiral" problems as well as
potential for greater efficiencies.
|
|
- Helping Seniors Make Smart Prescription Drug Decisions under the New Medicare Prescription Drug Legislation
- Donald W. Kemper, MPH, Chairman and Chief Executive
Officer
- Healthwise, Inc.
|
|
- Mr. Kemper discusses the concept of
"Information Therapy" applied to senior consumer prescription drug
decision-making.
|
|
|
-
Overview of the New Medicare-Endorsed Prescription Drug Discount Card Program
John Richardson, Director of the Medicare Practice
The Health Strategies Consultancy LLC
|
|
- This presentation briefly summarizes how the
Medicare Prescription Drug Discount cards work.
|
|
|
-
Implications of a Medicare Prescription Drug Benefit and Discount Card for Residents of Long-Term Care Facilities
Mary Jo Carden, RPh, Esq., Principal
Dumbarton Group & Associates, LLC
|
|
- This 57 slide presentation provides an Overview of long-term care pharmacy
(LTCP) Services; discusses how LTC pharmacies provide to residents of long-term care facilities;
addresses the Current prescription payment systems for LTCP; lists the History of LTCP’s work with Congress and regulatory agencies;
and closes with a discussion of the
Implications of the discount card program and transitional assistance for residents of nursing facilities;
Implications under the Medicare prescription drug benefit; and Implications in other long-term care settings including assisted living facilities.
|
|
-
Helping Seniors Make Smart Prescription Drug Decisions under the New Medicare Prescription Drug Legislation
Hal Prink, Medicare Patient Advocate
Senior's Voice for Healthcare Rights
|
|
- This presentation addresses the Need for Medicare Beneficiary Education regarding prescription drug coverage
options; the complexity of Options; the Effective Principles for Adult Learning; the Education Roles for CMS, Providers, Employers, Advocacy groups, Health Plans and Card Providers; and the need for
commitment to place a high priority on beneficiary education so that each senior/caregiver chooses options that are best for them or family members.
|
|
|
-
Will Employers Continue to Offer Prescription Drug Coverage Following Implementation of the New Medicare Prescription Drug Program?
Lisa Zeitel, MPH, Principal and National Leader
Managed Pharmacy Group
Mercer Human Resource Consulting
Derek Guyton, FSA, Principal
Mercer Human Resource Consulting
|
|
- This presentation addresses the current environment for employers offering Rx coverage to retiree and covers
topics including: winners and Losers; Issues Employers Are Wrestling With Today; Key Questions Employers are Asking; How Employers View Their Options; Long Term Issues for Employers; and Predictions.
|
|
-
Far Reaching and Immediate Impacts of the New Medicare Prescription Legislation on MCOs and PBMs
Mark W. Owen, Vice President and General Manager
Medica Center for Healthy Aging
|
|
- This presentation addresses the implications
of the Medicare Advantage provisions of the Medicare Modernization Act for
health plans, and the implications of various provisions of the Act for PBMs,
and provides a brief strategic analysis of the Medicare Advantage programs.
|
|
-
The Implications of Medicare Drug Benefits for PBMs and Retiree Health Benefit Plans
Bill Rosenberg, Director, Health Care Practice
PricewaterhouseCoopers LLP, Human Resource Services
|
|
- Review key features of the Part D Rx benefit,
and examine what’s “new” for PBMs. This presentation continues with
specific examples of new challenges for PBMs including: Responding to employer customers that currently offer retiree
health benefits; Coordinating with employment-based retiree health plans;
and Administering HSAs.
|
|
- IRS and DOL Stay Busy Filling
Gaps in HSA Rules
Ashley Gillihan
Alston & Bird, LLP
|
|
- An overview of IRS and DOL HSA guidance issued
so far in 2004. Ashley discusses the impact the recently issued IRS and DOL
guidance has on HSAs and we will discuss the wish list for future guidance. This
presentation is also available as a live
audioconference.
|
|
- What employers need to know about Health
Savings Accounts
- Doug Kronenberg, Chief
Strategy Officer
Lumenos
-
|
|
Health Savings Accounts (HSAs) enables
employers and employees a better way to fund their healthcare costs.
HSA expert, Doug Kronenberg will share his insight on the implications
of HSAs industry-wide and what this means to employers who are looking
to implement a HSA into their organization. He will address important
topics such as:
- Who can offer HSAs?
- What is the difference between HSAs,
HRAs and FSAs?
- Can these accounts co-exist?
- Who is implementing HSAs?
- How will HSAs expand the reach of
consumer-driven health care?
This presentation is also available as
a live
audioconference.
|
 |
- Roundtable Discussion on Medicare Reform Market
Opportunities
- Moderator: Claire Thayer, Vice President Research and
Development
- MCOL
|
|
-
Various members of the faculty exchange
perspectives on market opportunities resulting from the
Medicare Prescription Drug, Improvement and Modernization Act.
|
|
|